| LDR | | 01761nmm uu200385 4500 |
| 001 | | 000000334405 |
| 005 | | 20240805180234 |
| 008 | | 181129s2017 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780438310209 |
| 035 | |
▼a (MiAaPQ)AAI10970783 |
| 035 | |
▼a (MiAaPQ)OhioLINK:osu1492420724807522 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 082 | 0 |
▼a 616 |
| 100 | 1 |
▼a Borniger, Jeremy C. |
| 245 | 10 |
▼a Effects of Non-Metastatic Mammary Tumors and Cytotoxic Chemotherapy on Murine Sleep. |
| 260 | |
▼a [S.l.] :
▼b The Ohio State University.,
▼c 2017 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2017 |
| 300 | |
▼a 207 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 80-01(E), Section: B. |
| 500 | |
▼a Adviser: Randy Nelson. |
| 502 | 1 |
▼a Thesis (Ph.D.)--The Ohio State University, 2017. |
| 520 | |
▼a Cancer patients have idiopathic sleep problems that may persist for years after treatment cessation. The underlying contributors to sleep disruption in these patients are not well defined. Differing treatment (e.g., chemotherapy and/or radiother |
| 520 | |
▼a Therefore, the goal of the work presented herein was to tease apart different potential contributors to sleep disruption in cancer patients, by focusing on cancer treatment (i.e., cytotoxic chemotherapy) and cancer independently. Cancer and the |
| 590 | |
▼a School code: 0168. |
| 650 | 4 |
▼a Neurosciences. |
| 690 | |
▼a 0317 |
| 710 | 20 |
▼a The Ohio State University.
▼b Neuroscience. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 80-01B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0168 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2017 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T15001364
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자 |